Login / Signup

[ 177 Lu]Lu-DOTATATE peptide receptor radionuclide therapy-associated myeloid neoplasms: insights from the WHO pharmacovigilance database.

Jonathan VigneBasile ChrétienAnne-Laure BignonKarine Bouhier-LeporrierCharles Dolladille
Published in: European journal of nuclear medicine and molecular imaging (2022)
Keyphrases
  • adverse drug
  • pet ct
  • dendritic cells
  • bone marrow
  • acute myeloid leukemia
  • drug induced
  • emergency department
  • immune response
  • replacement therapy